Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05705167 |
|
Recruitment Status :
Terminated
(Significant difficulties in the recruitment of patients)
First Posted : January 30, 2023
Last Update Posted : April 26, 2024
|
Sponsor:
PharmaMar
Information provided by (Responsible Party):
PharmaMar
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | March 19, 2024 |
| Actual Study Completion Date : | April 19, 2024 |